Artiva Biotherapeutics, Inc. (ARTV)

10.96 +0.72 (+7.03%) USD  |  NASDAQ  |  May 01, 15:28
More

Artiva Biotherapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for ARTV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Innoviva, Inc. Upgrade
Rocket Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade